Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCellbxhealth Regulatory News (CLBX)

Share Price Information for Cellbxhealth (CLBX)

Share Price is delayed by 15 minutes
Get Live Data
1.80    0.075 (4.35%)
Bid:
1.70
Ask:
1.90
Spread: 0.20 (11.765%)
Market Cap: £35.05m
CLBX Live PriceLast checked at - London Stock Exchange

Intraday Cellbxhealth Share Chart

Holding(s) in Company

23 Dec 2025 09:15

RNS Number : 6610M
Cellbxhealth PLC
23 December 2025
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0034330679

Issuer Name

CelLBxHealth plc

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Conifer Management, L.L.C.

City of registered office (if applicable)

New York

Country of registered office (if applicable)

United States

4. Details of the shareholder

Name

City of registered office

Country of registered office

Pershing LLC

Jersey City

USA

5. Date on which the threshold was crossed or reached

18-Dec-2025

6. Date on which Issuer notified

22-Dec-2025

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

29.900000

0.000000

29.900000

340681395

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB0034330679

340681395

29.900000

Sub Total 8.A

340681395

29.900000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Gregory Alexander

Conifer Management, LLC

29.900000

29.900000%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Shares are held in private funds managed by Conifer Management, LLC

12. Date of Completion

22-Dec-2025

13. Place Of Completion

New York, NY

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLGZMZZLFLGKZG
Date   Source Headline
29th May 20267:00 amRNSMSA with Global Pharmaceutical Company
18th May 20267:00 amRNSCollaboration with AdventHealth for two studies
11th May 20267:00 amRNSQ1 trading update and outlook for 2026
30th Apr 20267:00 amRNSConfirmation of Q1 trading update
20th Apr 20267:00 amRNSResearch Collaboration with The Royal Marsden
16th Apr 20265:39 pmRNSBoard changes - Replacement
13th Feb 20267:00 amRNSAligning Regulatory Approach with Commercial Needs
16th Jan 20267:00 amRNSPreliminary Fourth Quarter 2025 Financial Results
12th Jan 20267:00 amRNSBoard changes
23rd Dec 20259:15 amRNSHolding(s) in Company
23rd Dec 20259:15 amRNSHolding(s) in Company
19th Dec 20255:51 pmRNSPDMR Dealing and ESOT Share Purchase
19th Dec 20255:51 pmRNSPDMR Dealing and ESOT Share Purchase
15th Dec 20252:41 pmRNSResults of General Meeting and Board Changes
2nd Dec 202511:11 amRNSAdditional Subscription
1st Dec 20255:44 pmRNSResult of Retail Offer
25th Nov 20255:40 pmRNSUpdate to Admission of Fundraising Shares
25th Nov 20258:00 amRNSLaunch of Retail Offer
25th Nov 20257:55 amRNSResult of Oversubscribed Placing and Subscription
24th Nov 20256:32 pmRNSProposed Placing and Subscription
18th Nov 20257:00 amRNSQIAGEN Collaboration and Co-Marketing Agreement
5th Nov 20256:16 pmRNSFurther Update on Funding
5th Nov 20257:00 amRNS-RCelLBxHealth Presents Proof-of-Concept Study
4th Nov 20257:00 amRNSExpert Consensus on CTCs; Update on Funding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.